CAS: 76822-21-4; (R)-3-(3,4-Dihydroxyphenyl)-2-Hydroxypropanoic Acid

该化合物是在心血管疾病中的潜在治疗作用;盐酸A的特点是有能力对自由基进行搜索,抑制氧化压力,使其成为药物研究的一个主题;此外,该化合物还显示出抗炎和抗冷却活动,可以加强血液循环,防止无化学损害;该化合物在水中溶解,有利于生物利用和吸收生物系统;其结构特征包括多种氢氧化合物组,有助于其再活性和与生物目标的相互作用;

结构式图片

欧盟法规

C&L通报

上下游产品

(Z)-3-(3,4-dihydroxyphenyl)-2-hydroxyacrylic acid clinopodic acid C (R)-(+)-rosmarinic acid lycopic acid A(+/-)-(R)-methyl 3-(3,4-dimethoxyphenyl)-2-hydroxypropanoate (R)-(+)-rosmarinic acid (2R)-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid (S)-PGME amide (2R)-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid (R)-PGME amide

合成工艺路线路线简述

    丹酚酸 B置于sodium Hydroxide体系中,用 乙醇 作为反应溶剂,化学反应 1.5H,反应生成 丹参素
    参考文献:一种丹酚酸b转化为丹参素的方法
    标题:一种丹酚酸b转化为丹参素的方法
    摘要:本发明公开的一种丹酚酸b转化为丹参素的方法,其首先采用ph调节剂将丹参提取液的ph调节到7.0~12.0,然后加热回流进行转化得到丹参提取转化液,转化温度为80oc~120°C,转化时间为0.5H~4H,最后采用ph调节剂将丹参提取转化液的ph调节到2.0~6.0.本发明丹酚酸b转化为丹参素较为彻底,转化后丹酚酸b含量低于1.0Mg/ml;转化过程中不需要使用乙醇,丙酮,乙酸乙酯等有机溶媒;转化后存放其含量稳定;操作简单,不需要投入设备.

    海关参考信息

    专利信息


    专利号:US-12173333-B2
    优先权日:2017-08-07
    标 题:Variants of family a DNA polymerase and uses thereof
    发明人:YBERT THOMAS; CHAMPION ELISE; VIVAR OMAR; SAID AHMED
    权利人:DNA SCRIPT
    摘要:The present invention relates to variant of Family A polymerases able to synthesize a nucleic acid fragment without template and to incorporate a reversible modified terminator nucleotide during the nucleic acid fragment synthesis. The present invention further relates to uses thereof for enzymatic synthesis of nucleic acid molecules.

    专利号:US-2024084338-A1
    优先权日:2022-11-22
    标 题 :Recombinant Escherichia coli for producing rosmarinic acid and its application thereof
    发明人:ZHOU JINGWEN; CHEN JIAN; WANG LIAN; ZENG WEIZHU; YU SHIQIN
    权利人:UNIV JIANGNAN
    摘要:The present disclosure discloses a recombinant Escherichia coli for producing rosmarinic acid and application thereof, belonging to the technical fields of genetic engineering and bioengineering. In the present disclosure, FjTA derived from Flavobacterium johnsoniae, endogenous hpaBC derived from E. coli, CbRAS derived from Coleus blumei, HPPR derived from Coleus scutellarioides, and Pc4CL1 derived from Petroselinum crispum are heterologously expressed in E. coli, realizing synthesis of rosmarinic acid. TcTAL derived from Trichosporon cutaneum and tyrC for removing feedback inhibition are introduced, further increasing synthesis throughput of caffeic acid, and PmLAAD derived from Proteus myxofaciens is heterologously expressed, realizing redistribution of L-DOPA. An endogenous gene menl is knocked out, improving the content and stability of a rosmarinic acid precursor. The recombinant strain constructed in the present disclosure can produce rosmarinic acid by fermentation at a yield of up to 511.2 mg/L, providing a new method for industrial production of rosmarinic acid.

    专利号:CN-103833546-A
    优先权日:2014-02-25
    标 题 :Asymmetric Synthesis of Optically Pure Danshensu and Its Derivatives

    专利号:CN-103833546-B
    优先权日:2014-02-25
    标 题:Asymmetric Synthesis of Optically Pure Danshensu and Its Derivatives

    专利号:CN-102863328-B
    优先权日:2012-05-15
    标 题:Synthesis method of tanshinol

    专利号:CN-104341481-B
    优先权日:2013-08-09
    标 题 :The synthesis and application of a kind of sulfonamide compounds
    成都科程生物科技开发有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.cogon-chem.com
    电话: 028-85171192👤
    📞成都科程生物科技开发有限公司 ⚠️参考联系方式

    销售电话:028-85171192
    邮箱:cogon_chem@hotmail.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/0031-9422(95)00967-1
    摘要:Li-Min Zhao, Xiao-Tian Liang, Lian-Niang Li. Prionitisides A and B, two phenolic glycosides from Salvia prionitis. Phytochemistry. 1996 Jun;42(3):899–901. doi: 10.1016/0031-9422(95)00967-1.
    参考文献:10.1007/s43450-022-00328-9
    摘要:Liu L, Li J, Zhang Z, Zhao Q, Yu H, Qiang C, Cao Y. Tanshinol Inhibits Periodontitis Through IκBα Promotion. Rev. Bras. Farmacogn. 2023 Jan 16;33(2):326–33. doi: 10.1007/s43450-022-00328-9.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知